Skip to main content
SpringerLink
Log in

Navigation and Clinical Trials

  • Chapter
  • First Online:
Team-Based Oncology Care: The Pivotal Role of Oncology Navigation

  • 871 Accesses

Abstract

Patient navigation can be a means to positively influence oncology clinical trial participation. With a navigation focus on minority and underserved populations, this care concept promotes a trusting relationship among the research staff and the patient population served. An overview of clinical trials is described followed by a historical perspective of clinical trials, and current mandates are reviewed. A background of known barriers to clinical trial participation is disclosed since this is a common focal point of the navigation development in disparate communities. With respect to the individuality of a healthcare system’s focus on increasing oncology clinical trial participation, different avenues of navigation are explored to promote success on this objective. A common foundation for each avenue to increase clinical trial participation is built on the trusting relationship that the navigator establishes with each patient. The logistics of navigation training with standardized metrics that can apply to any navigation program engaged in clinical trial promotion is described. Patient navigation can be employed as a reasonable way to increase oncology clinical trial participation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 69.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Burhansstipanov L, Krebs LU, Bradley A, Gamito E, Osborne K, Kaur JS. Lessons learned while developing “clinical trials education for native Americans” curriculum. Cancer Control. 2003;10(5):29–36. PMID: 14581902.

    Article  PubMed  Google Scholar 

  2. Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation. Transforming clinical research in the United States: challenges and opportunities: workshop summary. Washington, DC: National Academies Press, US; 2010. p. 6. Clinical Trials in Cancer. https://www.ncbi.nlm.nih.gov/books/NBK50895/

    Google Scholar 

  3. Cheng S, Dietrich M, Dilts D. A sense of urgency: evaluating the link between clinical trial development time and the accrual performance of Cancer Therapy Evaluation Program (NCI-CTEP) sponsored studies. Clin Cancer Res. 2010;16(22):5557–63. https://doi.org/10.1158/1078-0432.CCR-10-0133.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Fouada MN, Corbie-Smith G, Curb D, Howard BV, Mauton C, Simon M, Talavera G, Thompson J, Wang CY, White C, Young R. Special populations recruitment for the Women’s Health Initiative: successes and limitations. J Control Clin Trials. 2004;25:335–52.

    Article  Google Scholar 

  5. Baquet CR, Henderson K, Commiskey P, Morrow JN. Clinical trials—the art of enrollment. Semin Oncol Nurs. 2008;24(4):262–9. https://doi.org/10.1016/j.soncn.2008.08.006.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Ulrich CM, James JL, Walker EM, Stine SH, Gore E, Prestidge B, Michalski J, Gwede CK, Chamberlain R, Bruner DW. RTOG physician and research associate attitudes, beliefs and practices regarding clinical trials: implications for improving patient recruitment. Contemp Clin Trials. 2010;31(3):221–8.

    Article  PubMed  Google Scholar 

  7. Wujcik D, Wolff SN. Recruitment of African Americans to National Oncology Clinical Trials through a clinical trial shared resource. J Health Care Poor Underserved. 2010;21(1 Suppl):38–50. https://doi.org/10.1353/hpu.0.0251.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Ford JG, Howerton MW, Lai GY, Gary TL, Bolen S, Gibbons MC, Tilburt J, Baffi C, Tanpitukpongse TP, Wilson RF, Powe NR, Bass EB. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer. 2008;112:228–42. https://doi.org/10.1002/cncr.23157.

    Article  PubMed  Google Scholar 

  9. Joseph G, Dohan D. Diversity of participants in clinical trials in an academic medical center: the role of the ‘Good Study Patient?’. Cancer. 2009;115:608–15.

    Article  PubMed  Google Scholar 

  10. Brawley O. Recruitment of minorities into clinical trials. In: National Cancer Advisory Board, editors. Conference summary: recruitment and retention of minority participants in clinical cancer research. U.S. Department of Health and Human Services, National Cancer Institute, National Institutes of Health (NIH Pub. No. 96-4182); 1996.

    Google Scholar 

  11. Burhansstipanov L. Overcoming psycho-social barriers to Native American cancer screening research. In: National Cancer Advisory Board, editor. Conference summary: recruitment and retention of minority participants in clinical cancer research. U.S. Department of Health and Human Services, National Cancer Institute, National Institutes of Health (NIH Pub. No. 96-4182), November 1996. p. 40–2.

    Google Scholar 

  12. Cancer.Net. About clinical trials. 2007. www.cancer.net/navigating-cancer-care/how-cancer-treated/clinical-trials/about-clinical-trials. Accessed 8 Mar 2017.

  13. Dimond EP, St. Germain D, Nacpil LM, Zaren HA, Swanson SM, Minnick C, et al. Creating a “culture of research” in a community hospital: strategies and tools from the National Cancer Institute Community Cancer Centers Program. Clinical Trials (London, England). 2015;12(3):246–56. https://doi.org/10.1177/1740774515571141.

    Article  Google Scholar 

  14. Gonzalez M, Berger M, Bryant D, Ellison C, Harness J, Krasna M, et al. Using a minority matrix and patient navigation to improve accrual to clinical trials. Oncol Issues. 2011;March/April:59–60.

    Article  Google Scholar 

  15. Gonzalez M, Berger M, Bryant D, Ellison C, Harness J, Krasna M, et al. Using a minority matrix and patient navigation to improve accrual to clinical trials. March/April: Oncology Issues; 2011. p. 59–60.

    Google Scholar 

  16. National Cancer Institute. Cancer clinical trials factsheet. 2017. www.hahv.org/wp-content/uploads/2016/01/clinical-trial-fact-sheet.pdf

  17. National Comprehensive Cancer Network. About NCCN. 2017. https://www.nccn.org/about/default.aspx

  18. Freund K, Battaglia T, Calhoun E, Dudley D, Fiscella K, Paskett E, et al. National Cancer Institute Patient Navigation Research Program: methods, protocol, and measures. Cancer. 2008;113(12):3391–9. https://doi.org/10.1002/cncr.23960.

    Article  PubMed  Google Scholar 

  19. Commission on Cancer. Cancer program standards: ensuring patient centered care. 2016. https://www.facs.org/quality-programs/cancer/coc/standards

  20. Denicoff A, McCaskill-Stevens W, Grubbs S, Bruinooge S, Comis R, Devine P, et al. The National Cancer Institute-American Society of Clinical Oncology cancer trial accrual symposium: summary and recommendations. J Oncol Pract. 2013;9(6):267–76. https://doi.org/10.1200/JOP.2013.001119.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Wong RSL, Vikram B, Govern FS, Petereit DG, Maguire PD, Clarkson MR, et al. National Cancer Institute’s Cancer Disparities Research Partnership Program: experience and lessons learned. Front Oncol. 2014;4:303. https://doi.org/10.3389/fonc.2014.00303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Swanson J, Strusowski P, Mack N, Degroot J. Growing a navigation program using the NCCCP Navigation Assessment Tool. 2012. www.accc-cancer.org/oncology_issues/.../JA12-Growing-a-Navigation-Program.pdf. Accessed 5 Feb 2017.

    Article  Google Scholar 

  23. Newcomer B. A national system approach to oncology patient population management across the continuum of care: how we standardized navigation. Nurs Adm Q. 2014;38(2):138–46.

    Article  PubMed  Google Scholar 

  24. Willis A, Reed E, Pratt-Chapman M, Kapp H, Hatcher E, Vaitones V. Development of a framework for patient navigation: delineating roles across navigator types. J Oncol Navig Surviv. 2013;4(6):20–6.

    Google Scholar 

  25. Oncology Nursing Society. Oncology nurse navigator core competencies. 2017. www.ons.org/sites/default/files/ONNCompetencies_rev.pdf. Accessed 5 Mar 2017.

  26. Freeman H. Patient navigation: a community centered approach to reducing cancer mortality. J Cancer Educ. 2006;21(1):S11–4. https://doi.org/10.1207/s15430154jce2101s_4.

    Article  PubMed  Google Scholar 

  27. Moffitt K, Brogan F, Brown C, Kasper M, Rosenblatt J, Smallridge R, et al. Statewide cancer clinical trial navigation service. J Oncol Pract. 2010;6(3):127–32. https://doi.org/10.1200/JOP.200006.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Holmes D, Majo J, Lyonga D, Alleyne R, Clayton S. Increasing minority patient participation in cancer clinical trials using oncology nurse navigation. Am J Surg. 2012;203(4):415–22. https://doi.org/10.1016/j.amjsurg.2011.02.005.

    Article  PubMed  Google Scholar 

  29. Germain D, Dimond E, Olesen K, Ellison C, Nacpil N, Gansauer L, Carrigan A, Igo K, Gonzalez M. The NCCCP Patient Navigation Project using patient navigators to enhance clinical trial education and promote accrual. Oncology Issues. 2014;May–June:44–53.

    Article  Google Scholar 

  30. Steinberg ML, Fremont A, Khan DC, Huang D, Knapp H, Karaman D, Forge N, Andre K, Chaiken LM, Streeter OE. Lay patient navigator program implementation for equal access to cancer care and clinical trials. Cancer. 2006;107:2669–77. https://doi.org/10.1002/cncr.22319.

    Article  PubMed  Google Scholar 

  31. Gorelick P, Harris Y, Burnett B, Bonecutter F. The recruitment triangle: reasons why African Americans enroll, refuse to enroll, or voluntarily withdraw from a clinical trial. J Natl Med Assoc. 1998;90:141–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Kanekar S, Petereit D. Walking forward: a program designed to lower cancer mortality rates among American Indians in Western South Dakota. South Dakota Med. 2009;62(4):151–9.

    Google Scholar 

  33. Guadagnolo BA, Petereit DG, Helbig P, Koop D, Kussman P, Dunn EF, Patnaik A. Involving American Indians and medically underserved rural populations in cancer clinical trials. Clinical Trials (London, England). 2009;6(6):610–7. https://doi.org/10.1177/1740774509348526.

    Article  Google Scholar 

  34. McClung EC, Davis SW, Jeffrey SS, Kuo M-C, Lee MM, Teng NNH. Impact of navigation on knowledge and attitudes about clinical trials among Chinese Patients undergoing treatment for breast and gynecologic cancers. J Immigr Minor Health. 2013;17(3):976–9.

    Article  Google Scholar 

  35. Cartmell KB, Bonilha HS, Matson T, Bryant DC, Zapka JG, Bentz TA, et al. Patient participation in cancer clinical trials: a pilot test of lay navigation. Contemp Clin Trials Commun. 2016;15(3):86–93. https://doi.org/10.1016/j.conctc.2016.04.005.

    Article  Google Scholar 

  36. Fouad M, Acemgil A, Bae S, Forero A, Lisovicz N, Martin M, et al. Patient navigation as a model to increase participation of African Americans in cancer clinical trials. J Oncol Pract. 2016;12(6):556–63. https://doi.org/10.1200/JOP.2015.008946.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Cancer Partnership. Clinical Trials Program at Metropolitan Nashville General Hospital. 2017. www.cancer-alliance.org/research/clinical-trials-program-at-metropolitan-nashville-general-hospital. Accessed 26 Mar 2017.

  38. EMPACT. General approaches to minority recruitment for cancer clinical trials: a presentation by the EMPACT consortium. 2012. http://tuh7143yoi527qz2743fa3x7.wpengine.netdna-cdn.com/wp-content/uploads/2012/05/General_Approaches_e508.pdf.

  39. St Joseph Hospital. St Joseph Hospital community health needs assessment report. 2014. /www.sjo.org/For-Community/Community-Benefits-Plan.aspx.

  40. Germain D, Dimond E, Olesen K, Ellison C, Nacpil N, Gansauer L, et al. The NCCCP Patient Navigation Project using patient navigators to enhance clinical trial education and promote accrual. Oncology Issues. 2014;May–June:44–53.

    Google Scholar 

  41. Gibbs Cancer Center & Research Institute. 2016 Annual report. 2016. https://gibbscancercenter.org/news-media/annual-reports/#1457639866050-77e7953e-4cd2.

  42. Natale-Pereira A, Enard KR, Nevarez L, Jones LA. The role of patient navigators in eliminating health disparities. Cancer. 2011;117:3543–52. https://doi.org/10.1002/cncr.26264.

    Article  PubMed  Google Scholar 

  43. Gunn CM, Clark JA, Battaglia TA, Freund KM, Parker VA. An assessment of patient navigator activities in breast cancer patient navigation programs using a nine-principle framework. Health Serv Res. 2014;49:1555–77. https://doi.org/10.1111/1475-6773.12184.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Fillion L, Cook S, Veillette A, Aubin M, de Serres M, Rainville F, et al. Professional navigation framework: elaboration and validation in a Canadian context. Oncol Nurs Forum. 2012;39(1):E58–69. https://doi.org/10.1188/12.ONF.E58-E69.

    Article  PubMed  Google Scholar 

  45. Calhoun EA, Whitley EM, Esparza A, Ness E, Greene A, Garcia R, et al. A national patient navigator training program. Health Promot Pract. 2010;11(2):205–15. https://doi.org/10.1177/1524839908323521.

    Article  PubMed  Google Scholar 

  46. Bryant D, Williamson D, Cartmell K, Jefferson M. A lay patient navigation training curriculum targeting disparities in cancer clinical trials. J Black Nurses Assoc. 2011;22(2):68–75.

    Google Scholar 

  47. EMPACT. ENACCT’s free E-learning series primary care provider training program. 2017. http://empactconsortium.com/resource/enaccts-free-e-learning-series-primary-care-provider-training-program.

  48. Germain D, Dimond E, Olesen K, Ellison C, Nacpil N, Gansauer L, et al. The NCCCP Patient Navigation Project using patient navigators to enhance clinical trial education and promote accrual. Oncol Issues. 2014;May–June:44–53.

    Google Scholar 

  49. Ghebre RG, Jones LA, Wenzel J, Martin MY, Durant R, Ford JG. State-of-the-science of patient navigation as a strategy for enhancing minority clinical trial accrual. Cancer. 2014;120(7):1122–30. https://doi.org/10.1002/cncr.28570.

    Article  PubMed  Google Scholar 

  50. Germain D, Dimond E, Olesen K, Ellison C, Nacpil N, Gansauer L, Carrigan A, Igo K, Gonzalez M. The NCCCP Patient Navigation Project using patient navigators to enhance clinical trial education and promote accrual. Oncol Issues. 2014;May–June:44–53.

    Article  Google Scholar 

  51. Bellomo C, Christensen D, Strusowski T. Seasoned navigator: a case study on care transitions in genomic testing and timely treatment decision-making. J Navig Surviv. 2016;7(4):33–4.

    Google Scholar 

  52. Academy of Oncology Nurse Navigators. Standardized metrics source document. 2017. www.aonnonline.org/metrics-source-document. Accessed 5 Mar 2017.

  53. Strusowski T, Sein E, Johnston D, Gentry S, Bellomo C, Brown E, et al. Standardized evidence-based oncology navigation metrics for all models: a powerful tool in assessing the value and impact of navigation programs. J Navig Surviv. 2017;8(5):220–43.

    Google Scholar 

  54. Irinotecan Hydrochloride and Cetuximab with or without Ramucirumab in treating patients with advanced colorectal cancer with progressive disease after treatment with Bevacizumab-Containing Chemotherapy.

    Google Scholar 

  55. NCI had no American Indians enrolled in the study and were willing to allow Chuck to take part to determine if the medications reacted differently among this underserved population.

    Google Scholar 

  56. Innovation Cancer. Clinical trials. 2015. www.innovationcancer.com/For-Patients/Clinical-Trials.aspx.

Download references

Author information

Authors and Affiliations

  1. Novant Health Derrick L. Davis Cancer Center, Winston-Salem, NC, USA

    Sharon Gentry RN, MSN, ONN-CG, AOCN, CBCN

  2. Native American Cancer Research Corporation, Pine, CO, USA

    Linda Burhansstipanov MSPH, DrPH

Authors
  1. Sharon Gentry RN, MSN, ONN-CG, AOCN, CBCN
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Linda Burhansstipanov MSPH, DrPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sharon Gentry RN, MSN, ONN-CG, AOCN, CBCN .

Editor information

Editors and Affiliations

  1. Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

    Lillie D. Shockney

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gentry, S., Burhansstipanov, L. (2018). Navigation and Clinical Trials. In: Shockney, L. (eds) Team-Based Oncology Care: The Pivotal Role of Oncology Navigation. Springer, Cham. https://doi.org/10.1007/978-3-319-69038-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-69038-4_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-69037-7

  • Online ISBN: 978-3-319-69038-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation